Electromed Stock Shares Owned By Institutions
| ELMD Stock | USD 15.77 0.41 2.53% |
Electromed fundamentals help investors to digest information that contributes to Electromed's financial success or failures. It also enables traders to predict the movement of Electromed Stock. The fundamental analysis module provides a way to measure Electromed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Electromed stock.
Electromed | Shares Owned By Institutions |
Electromed Company Shares Owned By Institutions Analysis
Electromed's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Electromed Shares Owned By Institutions | 32.78 % |
Most of Electromed's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Electromed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Electromed Shares Owned By Institutions Driver Correlations
Understanding the fundamental principles of building solid financial models for Electromed is extremely important. It helps to project a fair market value of Electromed Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since Electromed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Electromed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Electromed's interrelated accounts and indicators.
Click cells to compare fundamentals
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 32.78% of Electromed are shares owned by institutions. This is 26.57% lower than that of the Health Care Equipment & Supplies sector and 40.82% lower than that of the Health Care industry. The shares owned by institutions for all United States stocks is 16.4% higher than that of the company.
Electromed Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Electromed's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics of similar companies.Electromed is currently under evaluation in shares owned by institutions category among related companies.
Electromed Current Valuation Drivers
We derive many important indicators used in calculating different scores of Electromed from analyzing Electromed's financial statements. These drivers represent accounts that assess Electromed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Electromed's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 129.3M | 96.7M | 81.7M | 90.6M | 81.6M | 85.7M | |
| Enterprise Value | 118.9M | 84.9M | 73.6M | 83.4M | 75.1M | 78.8M |
Electromed Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0721 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 125.4 M | ||||
| Shares Outstanding | 8.61 M | ||||
| Shares Owned By Insiders | 26.69 % | ||||
| Shares Owned By Institutions | 32.78 % | ||||
| Number Of Shares Shorted | 36.41 K | ||||
| Price To Earning | 23.66 X | ||||
| Price To Book | 3.10 X | ||||
| Price To Sales | 2.42 X | ||||
| Revenue | 48.07 M | ||||
| Gross Profit | 36.52 M | ||||
| EBITDA | 4.62 M | ||||
| Net Income | 3.17 M | ||||
| Cash And Equivalents | 8.15 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 161 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 4.83 X | ||||
| Book Value Per Share | 4.69 X | ||||
| Cash Flow From Operations | 1.31 M | ||||
| Short Ratio | 1.20 X | ||||
| Earnings Per Share | 0.45 X | ||||
| Target Price | 26.0 | ||||
| Number Of Employees | 170 | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 141.13 M | ||||
| Total Asset | 45.81 M | ||||
| Retained Earnings | 18.79 M | ||||
| Working Capital | 29.73 M | ||||
| Current Asset | 15.82 M | ||||
| Current Liabilities | 3.07 M | ||||
| Net Asset | 45.81 M |
About Electromed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Electromed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.Moving together with Electromed Stock
| 0.66 | CAH | Cardinal Health Earnings Call This Week | PairCorr |
Moving against Electromed Stock
| 0.77 | SSY | SunLink Health Systems | PairCorr |
| 0.72 | TFX | Teleflex Incorporated Earnings Call This Week | PairCorr |
| 0.66 | AHG | Akso Health Group | PairCorr |
| 0.65 | MMSI | Merit Medical Systems | PairCorr |
| 0.52 | CTKB | Cytek Biosciences Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Electromed Piotroski F Score and Electromed Altman Z Score analysis. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.